Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Last year, the city of Flint, Michigan, burst into the world spotlight after its children were exposed to lead in drinking water. 5 percent of the children screened there had high blood lead levels. Flint is no aberration. In fact, it doesn't even rank among the most dangerous lead hotspots in America. In all, Reuters found nearly 3,000 areas with recently recorded lead poisoning rates at least double those in Flint during the peak of that city's contamination crisis. And more than 1,100 of these communities had a rate of elevated blood tests at least four times higher. The poisoned places ... stretch from Warren, Pennsylvania, a town on the Allegheny River where 36 percent of children tested had high lead levels, to a zip code on Goat Island, Texas, where a quarter of tests showed poisoning. In some pockets of Baltimore, Cleveland and Philadelphia, where lead poisoning has spanned generations, the rate of elevated tests over the last decade was 40-50 percent. Like Flint, many of these localities are plagued by legacy lead: crumbling paint, plumbing, or industrial waste left behind. Unlike Flint, many have received little attention or funding to combat poisoning. Even in some of the highest risk areas around the country, many small children go untested. In South Bend, Indiana, where health officials face a cash crunch, lead testing is in sharp decline even as existing data points to a serious problem. In one tract there, 31 percent of small children tested from 2005 to 2015 had high levels - more than six times Flint's rate last year.

Note: Read more about the widespread lead contamination in low-income neighborhoods throughout the US. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health.

Celiac disease, and, more generally, gluten intolerance, is a growing problem worldwide, but especially in North America and Europe, where an estimated 5% of the population now suffers from it. Symptoms include nausea, diarrhea, skin rashes, macrocytic anemia and depression. It is ... associated with numerous nutritional deficiencies as well as reproductive issues and increased risk to thyroid disease, kidney failure and cancer. Here, we propose that glyphosate, the active ingredient in the herbicide, Roundup, is the most important causal factor in this epidemic. Fish exposed to glyphosate develop digestive problems that are reminiscent of celiac disease. Celiac disease is associated with imbalances in gut bacteria that can be fully explained by the known effects of glyphosate on gut bacteria. Celiac disease patients have an increased risk to non-Hodgkin's lymphoma, which has also been implicated in glyphosate exposure. Reproductive issues associated with celiac disease, such as infertility, miscarriages, and birth defects, can also be explained by glyphosate. Glyphosate residues in wheat and other crops are likely increasing recently due to the growing practice of crop desiccation just prior to the harvest. We conclude with a plea to governments to reconsider policies regarding the safety of glyphosate residues in foods.

Note: As this is from a scientific journal, the language may not be easy to follow, yet the link between RoundUp, which contains glyphosate, and gluten intolerance is clear. This chart from the article shows how increasing incidence of thyroid cancer relates to increasing use of glyphosate on corn and soy crops in the US. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

At the age of 46, DeWayne Johnson is not ready to die. But with cancer spread through most of his body, doctors say he probably has just months to live. Now Johnson, a husband and father of three in California, hopes to survive long enough to make Monsanto take the blame for his fate. Johnson will become the first person to take the global seed and chemical company to trial on allegations that it has spent decades hiding the cancer-causing dangers of its popular Roundup herbicide products – and his case has just received a major boost. Last week Judge Curtis Karnow issued an order clearing the way for jurors to consider not just scientific evidence related to what caused Johnson’s cancer, but allegations that Monsanto suppressed evidence of the risks of its weed killing products. “The internal correspondence noted by Johnson could support a jury finding that Monsanto has long been aware of the risk that its glyphosate-based herbicides are carcinogenic ... but has continuously sought to influence the scientific literature to prevent its internal concerns from reaching the public sphere and to bolster its defenses in products liability actions,” Karnow wrote. Johnson’s case ... is at the forefront of a legal fight against Monsanto. Some 4,000 plaintiffs have sued Monsanto alleging exposure to Roundup caused them, or their loved ones, to develop non-Hodgkin lymphoma (NHL).

Note: As major lawsuits like this one against Monsanto begin to unfold, the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. A recent independent study published in a scientific journal found a link between glyphosate and gluten intolerance. Internal FDA emails suggest that the food supply contains far more glyphosate than government reports indicate. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

The World Health Organization said on Monday it hoped to conduct a full review by the end of the year of a dengue vaccine that was suspended last week in the Philippines. On Friday, the department of health halted its dengue immunization program after the manufacturer, French drug company Sanofi Pasteur, announced the vaccine, [commonly known as Dengvaxia], must be strictly limited due to evidence it can worsen dengue in people not previously exposed to the infection. The government of Brazil, where dengue is common, confirmed it already had recommended restricted use of the vaccine. Amid mounting public concern, Sanofi explained its "new findings" at a news conference in Manila on Monday but did not say why action was not taken after a WHO report in mid-2016 that identified the risk the company was now flagging. Nearly 734,000 children ... in the Philippines have received one dose of the vaccine as part of a programme that cost 3.5 billion pesos (more than $80 million Cdn). The Philippines Department of Justice on Monday ordered the National Bureau of Investigation to look into "the alleged danger to public health ... and if evidence so warrants, to file appropriate charges." There was no indication that Philippines health officials knew of any risks. However, the WHO said in a July 2016 research paper that "vaccination may be ineffective or may theoretically even increase the future risk" of severe dengue illness in people who hadn't been exposed to it prior to their first vaccination.

Note: Read more about this and about the way vaccines dangers are being covered up on this webpage. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

The US government missed the opportunity to curb sales of the drug that kickstarted the opioid epidemic when it secured the only criminal conviction against the maker of OxyContin a decade ago. Purdue Pharma hired Rudolph Giuliani, the former New York mayor and now Donald Trump’s lawyer, to head off a federal investigation in the mid-2000s into the company’s marketing of the powerful prescription painkiller at the centre of an epidemic estimated to have claimed at least 300,000 lives. While Giuliani was not able to prevent the criminal conviction over Purdue’s fraudulent claims for OxyContin’s safety and effectiveness, he was able to reach a deal to avoid a bar on Purdue doing business with the federal government which would have killed a large part of the multibillion-dollar market for the drug. The former New York mayor also secured an agreement that greatly restricted further prosecution of the pharmaceutical company and kept its senior executives out of prison. The US attorney who led the investigation, John Brownlee, has ... expressed surprise that Purdue did not face stronger action. Purdue is now facing ... civil lawsuits [in] New York, Texas and five other states. But Brownlee was the first, and so far only, prosecutor to secure a criminal conviction against the drug maker. Brownlee’s office discovered training videos in which reps acted out selling the drug using the false claims. “This was ... pushed from the highest levels of the company,” said Brownlee.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma.

Electromagnetic radiation from power lines, wi-fi, phone masts and broadcast transmitters poses a ‘credible’ threat to wildlife, a new report suggests. An analysis of 97 studies by the EU-funded review body EKLIPSE concluded that radiation is a potential risk to insect and bird orientation and plant health. The charity Buglife warned that despite good evidence of the harms there was little research ongoing to assess the impact, or apply pollution limits. The charity said ‘serious impacts on the environment could not be ruled out’ and called for 5G transmitters to be placed away from street lights, which attract insects, or areas where they could harm wildlife. Matt Shardlow, CEO of Buglife said: “We apply limits to all types of pollution to protect the habitability of our environment, but as yet, even in Europe, the safe limits of electromagnetic radiation have not been determined, let alone applied." As of March, 237 scientists have signed an appeal to the United Nations asking them to take the risks posed by electromagnetic radiation more seriously. The EKLIPSE report found that the magnetic orientation of birds, mammals and invertebrates such as insects and spiders could be disrupted by electromagnetic radiation (EMR). It [found] that plant metabolism is also altered by EMR. The authors of the review conclude that there is “an urgent need to strengthen the scientific basis of the knowledge on EMR and their potential impacts on wildlife.”

Note: For more along these lines, see concise summaries of deeply revealing news articles on the risks and dangers of wireless technologies.

For decades, Don Anderson of Seattle has been taking the same drug to help control the temporary bouts of immobility and muscle weakness caused by a rare and frightening genetic illness called periodic paralysis. The drug Anderson has been taking all these years was originally approved in 1958 and used primarily to treat the eye disease glaucoma under the brand name Daranide. The price has been on a roller coaster in recent years — zooming from a list price of $50 for a bottle of 100 pills in the early 2000s up to $13,650 in 2015, then plummeting back down to free, before skyrocketing back up to $15,001 after a new company, Strongbridge Biopharma, acquired the drug and relaunched it this spring. The zigzagging trajectory of the price of Daranide, now known as Keveyis, shows just how much freedom drug companies have in pricing therapies — and what a big business opportunity selling extremely-rare-disease drugs has become. In 2016, after The Washington Post asked questions about the high price of the drug, Sun Pharmaceutical said it would give the drug away free. Late last year, Sun agreed to sell Keveyis to a biotech company, Strongbridge Biopharma. In April, Strongbridge relaunched the drug. In August, it jacked the list price ... to $15,001 for a bottle of 100 pills. In a PowerPoint presentation for investors, Strongbridge Biopharma estimated that the annual price of treatment for the drug, Keveyis, would range from $109,500 to $219,000.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

One very expensive prescription drug threatened to financially cripple an entire city. Rather than using a health insurance company, Rockford, [Illinois] has, for years, paid its own health care costs for its 1,000 employees and their dependents. When Rockford got hit with the drug bill it was so enormous the mayor at the time set out to understand why. In 2015, two small children of Rockford employees were treated with Acthar, a drug that's been on the market since 1952. In 2001, Acthar sold for about $40 a vial. Today: more than $40,000. [Rockford Mayor Larry Morrissey] wanted to know how that could've happened. His investigation got nowhere until last year, when the Federal Trade Commission charged the drug manufacturer, Mallinckrodt, with violating antitrust laws. [The company] bought another drug that was Acthar's main competitor ... and put it on the shelf. Many of the doctors who prescribed a lot of Acthar also were getting money from the company that makes Acthar ... adding up to huge sums. Cities like Rockford [hire pharmacy benefit managers or PBMs] to negotiate down the price of drugs. The company negotiating prices for Rockford is Express Scripts. Express Scripts is many companies, not just the PBM. It also owns a pharmacy that sells expensive drugs, [as well as] a company that ships and packs expensive drugs. The city of Rockford was able to find out one more piece of the puzzle: that Express Scripts ... had a contract to be the exclusive distributor of Acthar.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

Pharmaceutical companies that spend billions of dollars to develop new drugs do not want competitors to profit from inexpensive generic copies of blockbuster medicines. To avoid rivals, they ... sometimes prevent generic drug companies from obtaining samples. Dr. Scott Gottlieb, the commissioner of the Food and Drug Administration, calls this “gaming the system,” and has vowed to stop it. On Thursday, the F.D.A. took a new tack and began posting a list of makers of brand-name drugs that have been the target of complaints, to persuade them to “end the shenanigans,” in the commissioner’s words. Congressional efforts to force the companies to hand over samples of their drugs to generic competitors have not been successful. Generic drug developers usually need between 1,500 to 5,000 units of the brand drug to develop their product and test it. Both the F.D.A. and the Federal Trade Commission say securing the samples can be difficult. The F.D.A.’s new list includes drug companies the agency said may be pursuing gaming tactics to delay generic competition. Along with the name of each business, the agency noted how many inquiries it received from generic drug companies seeking supplies. Celgene, [which makes drugs to treat cancer and immune-inflammatory diseases], tops the list. Other companies ... included GlaxoSmithKline, Pfizer, Valeant Pharmaceuticals International, BioMarin Pharmaceutical, Gilead Sciences and Novartis Pharmaceuticals.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

Tom Patterson lay in a coma. Three months earlier ... Patterson had suddenly fallen ill, so severely that he had to be medevaced to [University of California-San Diegos medical center]. The core of the problem was an infection with a superbug, a bacterium named Acinetobacter baumannii that was resistant to every antibiotic his medical team tried to treat it with. He was dying. We are running out of options to save Tom, [Tom's wife Steffanie Strathdee wrote to the hospitals head of infectious diseases, Dr. Robert Schooley]. What do you think about phage therapy? Phages are viruses [that] kill only specific strains of bacteria. They can quell infections without inducing a terrible diarrheal disease ... that occurs when the balance of bacteria in the gut is disrupted by antibiotics wiping out good bugs along with the bad. But for phage therapy to be deployed routinely in the United States, phages would have to be approved as drugs by the FDA. To treat an American patient with them now requires emergency compassionate-use authorization - effectively an acknowledgment that nothing with an FDA license can save the patients life. The FDA agreed to let the pair attempt phages. The whole treatment process was a scramble. Patterson, however, made it. He left the hospital ... having beaten the superbug using phages. He was the first person in the United States to have been successfully treated intravenously. Strathdee ... says she hopes to see phages become a routine option for serious infections, available to substitute for antibiotics.

Note: The unwarranted use of prescription antibiotics by doctors and the routine practice of adding antibiotics to animal feed in factory farms have led to what the Los Angeles Times recently called "a slow catastrophe" of antibiotic-resistant infections. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

To microdose is to take small amounts of LSD, which generate “subperceptual” effects that can improve mood, productivity and creativity. Michael Pollan’s new book, “How to Change Your Mind,” is not about that. It’s about taking enough LSD or psilocybin (mushrooms) to feel the colors and smell the sounds. If Pollan’s wide-ranging account has a central thesis, it’s that we’re still doing the hard work of rescuing the science of psychedelics from the “countercultural baggage” of the 1960s. In the mid-60s “the exuberance surrounding these new drugs gave way to moral panic,” and ... “the whole project of psychedelic science had collapsed.” Before collapsing, though, that project discovered in psychedelics the same potential that scientists are exploring as they reclaim it today: possible help in treating addiction, anxiety and depression, and “existential distress” — common in people “confronting a terminal diagnosis,” which of course, broadly speaking, is all of us. Pollan doesn’t give a lot of prime real estate to psychedelics’ naysayers. But given that those on LSD can appear to be losing their minds, and that the drug leaves one feeling emotionally undefended (a potential benefit as well as a profound risk), he does strongly recommend having an experienced guide in a proper setting when you trip. With those safeguards in place, he believes usage could be on the verge of more widespread acceptance.

Note: A recent clinical trial found psilocybin to be an extremely effective treatment for anxiety and depression. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream credibility.

Foodmakers will soon be required to disclose when their products contain genetically modified ingredients - but those labels may not be as obvious, or as comprehensive, as consumers expected. A proposed rule released by the Agriculture Department ... instructs foodmakers to use the term “bioengineered” to label such foods instead of “genetically modified.” The proposed rule ... will now undergo a public comment period and could be finalized as early as this summer. Congress passed a mandatory-labeling law in 2016. Food companies will have three options for disclosing the ingredients, the USDA said: a one-sentence label declaration, such as “contains a bioengineered food ingredient”; a standardized icon, such as the one used in the National Organic Program; or a QR code or other digital marker that directs shoppers to a website for more information. Under one plan, the USDA said it would exempt highly refined sugars and oils, such as those made from genetically modified corn, soybeans and sugar beets, from labeling. This would effectively exempt as much as 70 percent of covered food products from GMO labeling. Under another plan, the USDA would exempt products containing ingredients from mixed sources that were less than 5 percent genetically modified by weight. That ... is significantly higher than the 0.9 percent threshold observed by China, Russia and the European Union.

Note: For more along these lines, see concise summaries of deeply revealing news articles on GMOs and food system corruption.

Recent trials of psilocybin, a close pharmacological cousin to LSD, have demonstrated that a single guided psychedelic session can alleviate depression when drugs like Prozac have failed; can help alcoholics and smokers to break the grip of a lifelong habit; and can help cancer patients deal with their “existential distress” at the prospect of dying. At the same time, studies imaging the brains of people on psychedelics have opened a new window onto the study of consciousness, as well as the nature of the self and spiritual experience. Perhaps the most significant new evidence for the therapeutic value of psychedelics arrived in a pair of phase 2 trials (conducted at Johns Hopkins and NYU and published in the Journal of Psychopharmacology in 2016) in which a single high dose of psilocybin was administered to cancer patients struggling with depression, anxiety and the fear of death or recurrence. Eighty percent of the Hopkins cancer patients who received psilocybin showed clinically significant reductions in standard measures of anxiety and depression, an effect that endured for at least six months after their session. Results at NYU were similar. Curiously, the degree to which symptoms decreased in both trials correlated with the intensity of the “mystical experience” that volunteers reported, a common occurrence during a high-dose psychedelic session. Few if any psychiatric interventions for anxiety and depression have ever demonstrated such dramatic and sustained results.

Note: This entire article by best-selling author Michael Pollan is filled with the results of excellent studies in this exciting new field. If the above link fails, here is an alternative link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

One in 59 US children has autism, according to a new report from the US Centers for Disease Control and Prevention. The new estimate represents a 15% increase from two years prior and a 150% increase since 2000. Autism spectrum disorder, a developmental disability, is characterized by problems with communication and social interaction with accompanying repetitive behavior patterns. The CDC launched the Autism and Developmental Disabilities Monitoring Network in 2000 to collect data that would provide estimates of the prevalence of autism spectrum disorder and other developmental disabilities. The agency ... developed a methodology for estimating autism prevalence using information from children's health and education records. The new estimated rate of autism in the United States is based on data collected from 11 communities in Arizona, Arkansas, Colorado, Georgia, Maryland, Minnesota, Missouri, New Jersey, North Carolina, Tennessee and Wisconsin. About 8% of all 8-year old children living in the US [live in these communities]. Overall, fewer than half of the children identified with autism had received their first diagnosis by the time they were 4 years old, the new CDC report finds. Also, the definition of autism has changed through the decades. In the past, more than half of children identified with autism also had intellectual disability, and now it's about a third.

Note: The above article carefully avoids mentioning the link between autism and environmental toxins such as mercury additives in vaccines. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Fresh fears have been raised over the role of mobile phones in brain cancer after new evidence revealed rates of a malignant type of tumour have doubled in the last two decades. The new study, published in the Journal of Public Health and Environment ... set out to investigate the rise of an aggressive and often fatal type of brain tumour known as Glioblastoma Multiforme (GBM). [It found] that cases of GBM in England have increased from around 1,250 a year in 1995 to just under 3,000. The scientists at the Physicians’ Health Initiative for Radiation and Environment (PHIRE) say the increase of GBM has till now been masked by the overall fall in incidence of other types of brain tumour. The group said the increasing rate of tumours in the frontal temporal lobe “raises the suspicion that mobile and cordless phone use may be promoting gliomas”. Professor Denis Henshaw said: “Our findings illustrate the need to look more carefully at, and to try and explain the mechanisms behind, these cancer trends, instead of brushing the causal factors under the carpet and focusing only on cures.” The new study list causal factors aside from mobile phone use that may explain the GMB trend, including radiation from X-rays, CT scans and the fallout from atomic bomb tests in the atmosphere.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the risks of cell phones and wireless devices.

US government scientists have detected a weedkiller linked to cancer in an array of commonly consumed foods, emails obtained through a freedom of information request show. The Food and Drug Administration (FDA) has been testing food samples for residues of glyphosate, the active ingredient in ... widely used herbicide products, for two years, but has not yet released any official results. Documents obtained by the Guardian show the FDA has had trouble finding any food that does not carry traces of the pesticide. “I have brought wheat crackers, granola cereal and corn meal from home and there’s a fair amount in all of them,” FDA chemist Richard Thompson wrote to colleagues in an email last year regarding glyphosate. That internal FDA email ... is part of a string of FDA communications that detail agency efforts to ascertain how much of the popular weedkiller is showing up in American food. Glyphosate is best known as the main ingredient in Monsanto Co’s Roundup brand. More than 200m pounds are used annually by US farmers. Thompson’s detection of glyphosate ... will probably not be included in any official report. Separately, FDA chemist Narong Chamkasem found “over-the-tolerance” levels of glyphosate in corn, detected at 6.5 parts per million, an FDA email states. The legal limit is 5.0 ppm. An illegal level would normally be reported to the Environmental Protection Agency (EPA), but an FDA supervisor wrote to an EPA official that the corn was not considered an “official sample”.

Note: The negative health impacts of Monsanto's Roundup are well known. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

The European Union has made a key breakthrough to completely ban pesticides that harm bees and their crop pollination. The 28 member states got a large majority backing the ban on the three prevalent neonicotinoid pesticides which will take effect at the end of the year. The decision builds on a limited ban which has been in effect since 2013. Antonia Staats of the Avaaz campaign group on Friday called it a “beacon of hope for bees. Finally our governments are listening.” Over the past several years, there’s been an alarming drop in bee populations and there were fears it would start to seriously affect crop production since bees are necessary for the spread of pollen and reproduction.

Note: Neonicotinoid pesticides have been found to negatively impact bee reproduction. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

MDMA - the active ingredient in the banned street drug ecstasy - is safe and enhances the treatment of post-traumatic stress disorder when administered during psychotherapy, according to a new clinical trial. The US Food and Drug Administration-approved ... study included just 26 patients, all of them veterans, firefighters and police officers who developed PTSD as a result of trauma in the line of duty. PTSD ... affects about 8 million American in any given year. Continuing symptoms, including flashbacks and frightening thoughts, may lead to substance abuse, unemployment, family disruption and even suicide. Up to 72% of veterans who receive psychotherapy retain their PTSD diagnosis and frequently drop out of their treatment programs. "We only included people who had received prior treatment but still had clinically significant PTSD," [Dr. Michael C. Mithoefer, lead author of the study] said. Participants received ... about 13 hours of non-drug psychotherapy plus two eight-hour sessions of MDMA-assisted psychotherapy. Participants were randomly assigned to receive MDMA (orally) in one dose of either 30, 75 or 125 milligrams for each of the two MDMA-assisted psychotherapy sessions. One month after the second MDMA session, 68% of patients in the two higher-dose groups no longer qualified for a diagnosis of PTSD. One year later, 67% of all participants no longer qualified for a diagnosis of PTSD. Those participants who still met the criteria for PTSD experienced a reduction in symptoms, the researchers noted.

Note: Watch an engaging interview with one of the participants of the study at the link above. Read more about how MDMA has been found to be effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering "gene therapy" treatment: cures could be bad for business in the long run. "Is curing patients a sustainable business model?" analysts ask in an April 10 report entitled "The Genome Revolution." "The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow." Richter cited Gilead Sciences' treatments for hepatitis C, which achieved cure rates of more than 90 percent. The company's U.S. sales for these hepatitis C treatments peaked at $12.5 billion in 2015, but have been falling ever since. "GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients," the analyst wrote. "In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines. Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise."

Note: Many cancer treatments have been suppressed, sometimes in brutal ways, because the medical profession would lose the huge profits of traditional cancer treatments. Watch this video for undeniable evidence showing that this is the case. Read an excellent article on how the profiteering drug industry is crippling our children, possibly even intentionally. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Pregnant women exposed to high radiation levels from sources like cell phones, wireless devices and cell towers miscarried at nearly three times the rate as those exposed to low levels, according to new research. “I hope this study makes us rethink the notion that magnetic field non-ionizing radiation exposure is safe or has no health risk,” said lead author Dr. De-Kun Li. Cell phones, cordless phones and other wireless devices, appliances, power lines, smart-meter networks and cell towers generate non-ionizing radiation from magnetic fields. Writing in Scientific Reports, Li and his team call rapidly proliferating electromagnetic field emissions “a ubiquitous environmental exposure and a serious looming public health challenge.” For the study, more than 900 pregnant women in the San Francisco area carried meters that measured their exposure to electromagnetic field radiation. Expectant mothers with the highest exposure levels during their typical weekday routines were 2.7 times as likely to miscarry as women with the lowest levels. The results underscore the need for additional research into possible health harms of a technology to which virtually everyone in the U.S. is now exposed, whether by choice or circumstance, Li said. A federal study last year found an increased risk of cancer associated with magnetic field non-ionizing radiation exposure in rodents. Li called the findings from the National Toxicology Program “stunningly important.”

Note: The National Toxicology Program study mentioned above came to light in 2016 after scientists posted some of its preliminary findings to a public website. For more along these lines, see concise summaries of deeply revealing news articles on the risks of cell phones and wireless devices.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.